RORC and psoriasis: Although GSK2981278 is a highly potent and selective antagonist of RORγ in vitro, GSK2981278 exhibited limited efficacy in reduction of epithermal thickness (23% reduction vs placebo + IMQ control at 1% GSK2981278 ointment) in IMQ-induced mouse psoriasis-like inflammation model28.